UNSPSC 51293501: Pirandamine

This classification denotes a serotonin agonist with the molecular formula C17H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WC6V8L1Z13, chemically known as 1,3,4,9-tetrahydro-n,n,1-trimethylindeno(1,2-c)-pyran-1,ethylamine hydrochloride but generally known as pirandamine, which bears US NIH Compound Identifier 216376. European Medicines Agency schedules Pirandamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09893MIG.

UNSPSC 51293501 Pirandamine, a Commodity code, does not align with the state and local procurement activity recently tagged under it. The three recent opportunities show little to no actual pirandamine procurement; instead, they document naloxone systems, direct-to-manufacturer pharmacy programs, and generic pharmaceutical supply contracts—none of which involve pirandamine as a product line. The code appears to carry a classification mismatch in state and local procurement systems.

The recent opportunities span health and human services contexts across Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. The Texas Health and Human Services Commission released a Request for Information (HHS0017013, posted April 3, 2026) to explore direct-to-manufacturer prescription fulfillment capabilities without traditional pharmacy benefit manager intermediaries. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) to establish contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities. These opportunities reflect state health departments, county health systems, and cooperative purchasing bodies as issuing bodies, but none directly procure pirandamine. Until the code's application in state and local systems is corrected or active pirandamine opportunities emerge, pursue work under this code with caution—the current tagging suggests either system error or dormant demand.